Hi {{ session.user.profile.firstName }}

New! Introducing Ascentis Express 5 um HPLC Columns with Fused-Core Technology

Recorded Sep 21 2012 53 mins
Presented by
R. A Henry
Presentation preview: New! Introducing Ascentis Express 5 um HPLC Columns with Fused-Core Technology
Recommended for you:
  • Date
  • Rating
  • Views
  • Richard Mendel MD, a Spinal Neurosurgeon from Tampa, Florida, gives a presentaion on the Basics of Stem Cells. Stem Cell Treatments are becoming more popular, and it benefit all to know the basics of this growing science.
  • Th​is webinar will provide an overview on the topic of analyzing various fatty species in foods and methods to determine various classes from total fat to various lipid fractions and the wide variety of analyses available for fat determination. Topics discussed will include the analyses of fatty acid methyl esters (FAMES) in foods and the use of comprehensive two-dimensional gas chromatography (GC x GC) for the enhanced separation of highly complex mixtures. Advances in GC column stationary phases and new phases based on ionic liquid technology for the analyses of saturated and polyunsaturated FAMES will be discussed aswell as the use of GC×GC in the field of food lipid analysis. The considerable advantages of the two-dimensional approach (both with and without MS detection), in experiments related to a series of lipid volatiles (fatty acids, sterols, oxidation products, fatty alcohols, etc) will be illustrated.

    In this webinar, we will:

    > Overview the wide variety of methods available for the analysis of fat in foods.

    > Examine traditional and new classes of GC Stationary Phases for the evaluation of various FAME species.

    > Discuss the power of two-dimensional gas chromatography (GCxGC) for separating highly complex mixtures and how it can be combined with mass spectrometry for analyzing volatile and semi-volatile analytes
  • As developments in quantum computing accelerate and the potential to increase the capabilities of tomorrows computers becomes a reality, leading research scientists discuss their research at key international establishments.

    “Enabling processes and tools for research and fabrication of Qubits”, Dr David Haynes, Oxford Instruments

    “A valley-spin qubit in a carbon nanotube”,
    Dr Edward Laird, Materials Department, Oxford University

    “Next-generation cQED processors”,
    Dr. Alessandro Bruno, post-doc researcher, Quantum Computing Lab (QcLab), Kavli Institute of Nanoscience and QuTech, Delft University of Technology
  • Digital – a word which is ubiquitous within our industry now and no longer the exclusive domain of IT or marketing. It should not be seen as simply an enabler; intelligent and progressive digitisation is now a fundamental business need in all areas of pharma and healthcare.

    We present an exclusive webinar with global data centre and interconnectivity specialist Equinix, joined by digital and technology experts FFW and moderated by our own Paul Tunnah. This debate will provide practical insight and delve deep into the challenges at hand in managing the digitisation of our industry.

    Topics covered will include:
    •Why being digital is no longer an IT function but rather a business need – analysis and insight into the current market and the coming 3 to 5 years
    •Managing data – how pharma needs to change its IT foundations to remain commercially optimised in a changing healthcare environment, including the move from pill to patient
    •How industry can prepare – why connected is not enough – definition and benefits of interconnectivity, with learnings from the financial sector
  • Objectives:
    (1) Review the unique nutritional needs of preterm infants (2) Review the incidence and causes of extrauterine growth restriction (EUGR) in VLBW infants (3) Summarize the evidence regarding the impact of nutrition on neurodevelopmental outcomes (4) Define the protein and energy requirements of VLBW infants (5) Discuss a variety of nutritional strategies for meeting protein and energy requirements of VLBW infants
  • Because of worldwide demographic changes a dramatic increase of the geriatric population is expected in the next decades. While pediatric drug delivery principles are becoming integrated into the development of new medicines, drug developers are less prepared to appropriately address the specific needs of this booming patient population. This webinar tries to give an overview about the possible drug delivery strategies addressing old age dependent differences. There will be specifically focused on how patient convenience and compliance can be improved, how disease specific drug delivery strategies can help geriatric patients, and how learnings from pediatric drug development can be used as a platform towards geriatric drug delivery.
  • Chemical probes are powerful reagents with increasing impacts on biomedical research. However, probes of poor quality or that are used incorrectly generate misleading results. To help address these shortcomings, we are building a community-driven online resource to improve quality and convey current best practice.
    In this presentation, we will highlight some selected examples of promising, high quality chemical probes and probes of lesser value. We will discuss the prevalence of using lesser quality probes and the costs. We will then detail our plans to develop the Chemical Probes Portal, a web-based resource annotated by the chemical biology community that allows users to reference the most appropriate chemical probe (or probes) for a given protein target. The Portal will be an online community of scientists, reviewers, editors.
  • The importance of genetic variations in drug transporters for drug disposition and response has been increasingly recognized in the past decade. The drug transporter organic anion transporting polypeptide 1B1 (OATP1B1) is genetically polymorphic and plays a major role in hepatic uptake of a variety of clinically important drugs. Predicting the pharmacokinetic effect of these genetic variants on the drug disposition is critical for understanding the inter-individual variations to drug efficacy and safety. Corning TransportoCells was introduced to support in vitro assessment of drug interaction with SLC transporter. Specially, the newly developed TransportoCells OATP1B1 SNPs, alongside with OATP1B1 wild type, offer an in vitro tool kit for studying the potential impact of genetic variants on drug PK.

    This webinar will focus on the development and characterization of the newly available TransportoCells OATP1B1 genetic variants, three animal species Oatp family members and other drug transporters of emerging importance in drug development.
  • NIR has proven to be a fast, flexible, and reliable method along the pet food value chain; from incoming raw material inspection to in-process and final product testing, see how BUCHI NIRSolutions® can be used to increase plant efficiency, product quality, and profit margins.
    During this webinar, you will:
    • Gain an understanding of basic NIR theory and the reasons this technology has been implemented by pet food manufacturers
    • See how fast, qualitative NIR methods can ensure consistent quality of in-coming raw materials
    • Learn how to utilize quantitative NIR measurements, from raw material analysis to finished pet food product
    • Get introduced to our portfolio of NIRSolutions and learn how to integrate these technologies for ultimate process and quality control
  • Reproducibility is one of the pillars of the entire scientific method, a benchmark upon which the reliability of one’s research can be tested. Yet many authors struggle with the proper reporting of their statistical methods, leading to revision and often rejection. Our team of experts will provide recommendations, best practices, and real-life examples for presenting research that is transparent, robust, and most importantly, reproducible.

    Speakers and topics will include:

    • William Irish, PhD, MSc, Vice President, CTI Clinical Trial and Consulting Services, Raleigh, NC
    “Reporting of Statistical Methods and Results: Importance of Good Communication”
    • Dana Turner, Design and Methods Advisor, Headache: The Journal of Head and Face Pain
    “Best Practices for Reporting Methods and Statistics & Ways to Avoid Common Pitfalls”
    • Benjamin Hofner, Reproducible Research Editor, Biometrical Journal; FAU Erlangen-Nürnberg
    “Reproducible Research - A Review and Recommendations”
    • William G. Jacoby, Editor, American Journal of Political Science; Professor, Michigan State University
    “The Replication Policy at the American Journal of Political Science: Experiences during the First Six Months”

Embed in website or blog

Successfully added emails: 0
Remove all
  • Title: New! Introducing Ascentis Express 5 um HPLC Columns with Fused-Core Technology
  • Live at: Sep 21 2012 3:00 pm
  • Presented by: R. A Henry
  • From:
Your email has been sent.
or close
You must be logged in to email this